Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic Syndrome

Gateway Health Alliance

Status: Completed

Conditions: Obesity; Dyslipidemia; Metabolic Syndrome

Treatments: Dietary Supplement: IGOB131

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00645775

GHAIGOB131CT

Details and patient eligibility

About

The study investigated the use and efficacy of the seeds of African bush mango (Irvingia gabonensis)to control body weight, blood lipids and hormones in overweight and obese people.

Full description

To assess the effects of seeds of Irvingia gabonensis on body weight, fasting blood glucose, plasma total and LDL cholesterol in 102 overweight and obese participants.

The study was a 10 week randomized, double blind, placebo controlled design. participants were randomly divided into 2 groups of 51 participants each. Group 1 was the placebo group, while Group 2 was the active group. Each group received 2 daily doses of 125 mg (before meals) of either placebo or Irvingia gabonensis.

Weight as well as fasting blood was taken at baseline and at 4, 8 and 10 weeks. No major detary changes or exercises were suggested during the study period.

Enrollment: 102 patients

Sex: All

Ages: 19 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• BMI>26

Exclusion criteria

• Diabetics Pregnant and lactating Participating in any other weight reducing program Smokers

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

102 participants in 1 patient group, including a placebo group

1

Placebo Comparator group

Description:

Compare active to placebo

Treatment:

Dietary Supplement: IGOB131